Cancer Therapy

You have free access to this content

Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma

  1. Javier Mercapide1,
  2. Germana Rappa1,
  3. Fabio Anzanello1,
  4. Judy King2,†,
  5. Oystein Fodstad1,3,
  6. Aurelio Lorico1,‡,*

Article first published online: 3 AUG 2009

DOI: 10.1002/ijc.24809

Issue

International Journal of Cancer

International Journal of Cancer

Volume 126, Issue 5, pages 1206–1215, 1 March 2010

Additional Information

How to Cite

Mercapide, J., Rappa, G., Anzanello, F., King, J., Fodstad, O. and Lorico, A. (2010), Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Int. J. Cancer, 126: 1206–1215. doi: 10.1002/ijc.24809

Author Information

  1. 1

    Mitchell Cancer Institute, University of South Alabama, Mobile, AL

  2. 2

    Department of Pathology, University of South Alabama, Mobile, AL

  3. 3

    Department of Tumor Biology, The Norwegian Radium Hospital, Oslo, Norway

  1. †

    Department of Pathology, CAMC Memorial Hospital, Charleston, WV

  1. ‡

    Fax: +251-460-6994

*Mitchell Cancer Institute, University of South Alabama, 1660 Springhill Avenue, Mobile, AL 36604, USA

Publication History

  1. Issue published online: 27 DEC 2009
  2. Article first published online: 3 AUG 2009
  3. Accepted manuscript online: 3 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 28 JUL 2009
  5. Manuscript Received: 6 MAR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1171K)

References

  • 1
    Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492–507.
  • 2
    Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008; 62: 753–64.
  • 3
    Berg G, Blomquist E, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in brain tumours. Acta Oncol 2003; 42: 582–8.
  • 4
    Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowall NW, Hochberg FH, Waxman DJ, Breakefield XO, Chiocca EA. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome p450 2B1 gene. Hum Gene Ther 1994; 5: 969–78.
  • 5
    Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A, Cattaneo E, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6: 447–50.
  • 6
    Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846–51.
  • 7
    Wada T, Haigh JJ, Ema M, Hitoshi S, Chaddah R, Rossant J, Nagy A, van der Kooy D. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J Neurosci 2006; 26: 6803–12.
  • 8
    Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, Black PM, Aboody KS, Carroll RS. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7: 623–9.
  • 9
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A. J Neurosci Res 2003; 74: 760–8.
  • 10
    Heese O, Disko A, Zirkel D, Westphal M, Lamszus K. Neural stem cell migration toward gliomas in vitro. Neuro Oncol 2005; 7: 476–84.
  • 11
    Zhao D, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, Kim SU, Aboody KS. Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res 2008; 6: 1819–29.
  • 12
    Staflin K, Honeth G, Kalliomäki S, Kjellman C, Edvardsen K, Lindvall M. Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res 2004; 64: 5347–54.
  • 13
    Staflin K, Lindvall M, Zuchner T, Lundberg C. Instructive cross-talk between neural progenitor cells and gliomas. J Neurosci Res 2007; 85: 2147–59.
  • 14
    Yang SY, Liu H, Zhang JN. Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol 2004; 23: 381–9.
  • 15
    Barresi V, Belluardo N, Sipione S, Mudò G, Cattaneo E, Condorelli DF. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 2003; 10: 396–402.
  • 16
    Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006; 12: 5550–6.
  • 17
    Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz MZ, Najbauer J, Potter PM, Aboody KS. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 2007; 67: 22–5.
  • 18
    Aboody KS, Najbauer J, Danks MK. Stem and progenitor cellmediated tumor selective gene therapy. Gene Ther 2008; 15: 739–52.
  • 19
    Wei MX, Tamiya T, Rhee RJ, Breakefield XO, Chiocca EA. Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome p450 2B1 cancer gene therapy paradigm. Clin Cancer Res 1995; 1: 1171–7.
  • 20
    Rappa G, Kunke D, Holter J, Diep DB, Meyer J, Baum C, Fodstad O, Krauss S, Lorico A. Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin. Neuroscience 2004; 124: 823–30.
  • 21
    Lorico A, Mercapide J, Soloduschko V, Alexeyev M, Fodstad O, Rappa G. Primary neural stem/progenitor cells expressing endostatin or cytochrome p450 for gene therapy of glioblastoma. Cancer Gene Ther 2008; 15: 605–15.
  • 22
    Jessberger S, Clemenson GD,Jr, Gage FH. Spontaneous fusion and nonclonal growth of adult neural stem cells. Stem Cells 2007; 25: 871–4.
  • 23
    Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 2008; 8: 377–86.
  • 24
    Jounaidi Y, Hecht JE, Waxman DJ. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Cancer Res 1998; 58: 4391–401.
  • 25
    Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM, Carroll RS. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J Neurooncol 2006; 79: 125–33.
  • 26
    Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li S, Bowers M, Garcia E, Kim SU, Barish ME, Aboody KS, Glackin CA. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells 2008; 26: 1575–86.
View Full Article (HTML) Get PDF (1171K)